Cancer Letters Journal Citation Rate 2026
0304-3835
eISSN 1872-7980
Elsevier BV
NL
Q1 Quartile Top Tier
About Cancer Letters
Cancer Letters (CL) is a peer-reviewed academic journal covering Cancer, Hypoxia, and Metabolism and Cancer-related Molecular Pathways, published by Elsevier BV in NL, catalogued under ISSN 0304-3835 (e-ISSN 1872-7980). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 8.60 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4100 USD). OpenAlex records 19,260 works and 802,446 citations, with an h-index of 269.
Cancer Letters Citation Rate 2026 — In Context
Cancer Letters has a 2025 2-Year Citation Rate (OpenAlex) of 8.60, placing it in the Q1 quartile within the Cancer, Hypoxia, and Metabolism research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Cancer Letters operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Cancer Letters should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Letters against similar journals in the field, use our journal comparison tool.
Submission Tips for Cancer Letters
- Budget $4100 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Letters Compares
Compared against 158 journals in the same research areas.
| ISSN (Print) | 0304-3835 |
|---|---|
| ISSN (Online) | 1872-7980 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | $4100 USD |
In-depth profile & metrics
Cancer Letters is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4100.
In our subject taxonomy, Cancer Letters is classified under Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies and Human auditory perception and evaluation.
Cancer Letters is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 8.599.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer Letters
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 8.599 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Cancer Letters against similar publications in its field:
Related Journals in Your Field
-
Cell Reports Elsevier IF 64.50
-
Cell Death and Disease Springer Nature IF 64.50
-
Cancer Cell Elsevier IF 64.50
-
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Elsevier IF 64.50
-
Cell Death and Differentiation Springer Nature IF 64.50
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S106234763
Get weekly updates for Cancer, Hypoxia, and Metabolism journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.